BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32538846)

  • 1. Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer's Disease.
    Hernandes-Alejandro M; Montaño S; Harrington CR; Wischik CM; Salas-Casas A; Cortes-Reynosa P; Pérez Salazar E; Cazares-Apatiga J; Apatiga-Perez R; Ontiveros Torres MÁ; Perry G; Pacheco-Herrero M; Luna-Muñoz J
    J Alzheimers Dis; 2020; 76(2):553-569. PubMed ID: 32538846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease.
    Luna-Muñoz J; García-Sierra F; Falcón V; Menéndez I; Chávez-Macías L; Mena R
    J Alzheimers Dis; 2005 Sep; 8(1):29-41. PubMed ID: 16155347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal Expression and Distribution of MMP2 at Initial Stages of Alzheimer's Disease-Related Pathology.
    Terni B; Ferrer I
    J Alzheimers Dis; 2015; 46(2):461-9. PubMed ID: 26402409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease.
    García-Sierra F; Wischik CM; Harrington CR; Luna-Muñoz J; Mena R
    J Chem Neuroanat; 2001 Jul; 22(1-2):65-77. PubMed ID: 11470555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT; Trojanowski JQ; Lee VM
    Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain.
    Ercan-Herbst E; Ehrig J; Schöndorf DC; Behrendt A; Klaus B; Gomez Ramos B; Prat Oriol N; Weber C; Ehrnhoefer DE
    Acta Neuropathol Commun; 2019 Dec; 7(1):192. PubMed ID: 31796124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau.
    Schmidt ML; Huang R; Martin JA; Henley J; Mawal-Dewan M; Hurtig HI; Lee VM; Trojanowski JQ
    J Neuropathol Exp Neurol; 1996 May; 55(5):534-9. PubMed ID: 8627344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transglutaminase bonds in neurofibrillary tangles and paired helical filament tau early in Alzheimer's disease.
    Singer SM; Zainelli GM; Norlund MA; Lee JM; Muma NA
    Neurochem Int; 2002 Jan; 40(1):17-30. PubMed ID: 11738469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease.
    Keck S; Nitsch R; Grune T; Ullrich O
    J Neurochem; 2003 Apr; 85(1):115-22. PubMed ID: 12641733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early but not late conformational changes of tau in association with ubiquitination of neurofibrillary pathology in Alzheimer's disease brains.
    Ibarra-Bracamontes VJ; Escobar-Herrera J; Kristofikova Z; Rípova D; Florán-Garduño B; Garcia-Sierra F
    Brain Res; 2020 Oct; 1744():146953. PubMed ID: 32526294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease.
    Luna-Muñoz J; Chávez-Macías L; García-Sierra F; Mena R
    J Alzheimers Dis; 2007 Dec; 12(4):365-75. PubMed ID: 18198423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
    Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
    Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro.
    Shin RW; Lee VM; Trojanowski JQ
    J Neurosci; 1994 Nov; 14(11 Pt 2):7221-33. PubMed ID: 7525898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The identification of raft-derived tau-associated vesicles that are incorporated into immature tangles and paired helical filaments.
    Nishikawa T; Takahashi T; Nakamori M; Hosomi N; Maruyama H; Miyazaki Y; Izumi Y; Matsumoto M
    Neuropathol Appl Neurobiol; 2016 Dec; 42(7):639-653. PubMed ID: 26501932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain.
    Rohn TT; Rissman RA; Davis MC; Kim YE; Cotman CW; Head E
    Neurobiol Dis; 2002 Nov; 11(2):341-54. PubMed ID: 12505426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypersialylation is a common feature of neurofibrillary tangles and granulovacuolar degenerations in Alzheimer's disease and tauopathy brains.
    Nagamine S; Yamazaki T; Makioka K; Fujita Y; Ikeda M; Takatama M; Okamoto K; Yokoo H; Ikeda Y
    Neuropathology; 2016 Aug; 36(4):333-45. PubMed ID: 26685795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of neurofibrillary tangles and tau-associated phenotype in the rTgTauEC model of early Alzheimer's disease.
    Polydoro M; de Calignon A; Suárez-Calvet M; Sanchez L; Kay KR; Nicholls SB; Roe AD; Pitstick R; Carlson GA; Gómez-Isla T; Spires-Jones TL; Hyman BT
    J Neurosci; 2013 Aug; 33(33):13300-11. PubMed ID: 23946388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin is associated with early truncation of tau protein at aspartic acid(421) during the maturation of neurofibrillary tangles in Alzheimer's disease.
    García-Sierra F; Jarero-Basulto JJ; Kristofikova Z; Majer E; Binder LI; Ripova D
    Brain Pathol; 2012 Mar; 22(2):240-50. PubMed ID: 21919991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational change as one of the earliest alterations of tau in Alzheimer's disease.
    Weaver CL; Espinoza M; Kress Y; Davies P
    Neurobiol Aging; 2000; 21(5):719-27. PubMed ID: 11016541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.